Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus Paxlovid 150 + 100 mg Film Coated Tablets (Pfizer Europe, Belgium)
Clinical trial NCT05491330 · COMPLETED
Trial details
- NCT number
- NCT05491330
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-21
- Primary completion
- 2022-09-04
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.